NMPA Approval

Diphtheria，Tetanus and Acellular Pertussis Combined Vaccine，Adsorbed

Approval Number

国药准字S10970013

Company成都生物制品研究所有限责任公司

Registration Date

May 11, 2020

Drug Information

Generic Name

吸附无细胞百白破联合疫苗

Trade Name

山联泰

Dosage Form

注射剂

Strength

每瓶0.5ml。每1次人用剂量0.5ml，含无细胞百日咳疫苗效价不低于4.0IU，白喉效价不低于30IU，破伤风疫苗效价不低于40IU。

Drug Type

生物制品

Registration Date

May 11, 2020

Company Information

Applicant Company

Company Name成都生物制品研究所有限责任公司

Company Address

成都市锦江区锦华路三段379号

Manufacturing Company

Company Name成都生物制品研究所有限责任公司

Company Address

成都市锦江区锦华路三段379号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

吸附无细胞百白破联合疫苗 - NMPA 批准文号 | MedPath